mass spectrometry raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-02-09 and is reviewed periodically as new material appears.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Brazilian literature dates back to the 16th century, to the writings of the first Portuguese explorers in Brazil, such as Pero Vaz de Caminha, filled with descriptions of fauna, flora and commentary about the indigenous population that fascinated European readers. Brazil produced significant works in Romanticism—novelists such as Joaquim Manuel de Macedo and José de Alencar wrote novels about love and pain. Alencar, in his long career, also treated indigenous people as heroes in the Indigenist novels O Guarani, Iracema and Ubirajara. Machado de Assis, one of his contemporaries, wrote in virtually all genres and continues to gain international prestige from critics worldwide. Brazilian Modernism, evidenced by the Modern Art Week in 1922, was concerned with a nationalist avant-garde literature, while Post-Modernism brought a generation of distinct poets such as João Cabral de Melo Neto, Carlos Drummond de Andrade, Vinicius de Moraes, Cora Coralina, Graciliano Ramos, Cecília Meireles, and internationally known writers dealing with universal and regional subjects such as Jorge Amado, João Guimarães Rosa, Clarice Lispector and Manuel Bandeira. Brazil's most significant literary award is the Camões Prize, which it shares with the rest of the Portuguese-speaking world. As of 2016, Brazil has eleven recipients of the prize. Brazil also holds its own literary academy, the Brazilian Academy of Letters, a non-profit cultural organization aimed at perpetuating the care of the national language and literature.
On 16 January 2023 an Italian court approved the extradition of Silvia Panzeri, daughter of Pier Antonio. In January 2023 Panzeri pleaded guilty to his part of the conspiracy as part of a plea deal with the Belgian authorities. As part of the deal Panzeri will reveal the identities of those he bribed as well as those he conspired with. It is foreseen he will receive a sentence of five years of which four would be suspended. The remaining year would be served in prison or with an electronic bracelet, or a combination of both. This was only the second time that Belgian prosecutors have made a plea deal as they were previously not permissible in law. The German magazine Der Spiegel was given access to over 1,300 documents from the Belgian investigation. According to these documents, Panzeri's group received payment in cash from Qatar, Morocco, Mauritania and possibly Saudi Arabia. The group are described as "shockingly amateurish", because they stored the money they received in bribes in their apartments, made hundreds of unencrypted telephone calls and held a "conspiratorial meeting in a hotel that was full of surveillance cameras". Nevertheless, they operated undetected for years. A spreadsheet found on one computer lists 199 meetings and activities undertaken by a number of named people between April 2018 and December 2022.
=== Fertility aid === One of the most damaged areas of the body following chemotherapy is typically the uterus. Following uterine damage due to cancer treatment, follicle damage makes it difficult for individuals to get pregnant even if viable ova are present. With bone marrow stem cell transplants, chemotherapy patients have been able to increase their fertility as follicle damage is repaired. As follicles are necessary for ovum attachment to the endometrium, it is important for these areas to be repaired in order to increase fertility. For individuals who have sustained egg and follicle damage, IVF has been found to be more effective following bone marrow stem cell transplantation. One human clinical case has shown improvements of uterine lining thickness and overall endometrium repair following bone marrow stem cell transplantation. This repair allowed for the patient to successfully become pregnant and carry to term. Additional repairs following bone marrow stem cell transplant to the endometrium include increased vascularity and iron levels, with egg implantation clustering around areas with high blood flow.
== Metabolism == Studies of the metabolism of synephrine by monoamine oxidases derived from rat brain mitochondria showed that synephrine was a substrate for deamination by both MAO-A and MAO-B, with Km = 250 μM and Vmax = 32.6 nM/mg protein/30 minutes; there was some evidence for preferential deamination by MAO-A.
Sources: en.wikipedia.org
, where e is the engineering normal strain, L is the original length of the fiber and l is the final length of the fiber. The true shear strain is defined as the change in the angle (in radians) between two material line elements initially perpendicular to each other in the undeformed or initial configuration. The engineering shear strain is defined as the tangent of that angle, and is equal to the length of deformation at its maximum divided by the perpendicular length in the plane of force application, which sometimes makes it easier to calculate.
City Manager's office Finance Department Human Resources Department Information Technology Department Municipal Court Parks and Recreation administrative staff Public Works Engineering, Building and Planning divisions. The city provides its own fire department, police department, library system, and also provides both their own water supply and wastewater treatment through the Public Works Operations division. The current wastewater treatment plant was completed in 2009. In total the local government employs around 450 full- and part-time employees with the majority in Police, Fire, and Public Works Operations. The Albany city government was nationally recognized in 2009 and 2010 with the Certificate of Distinction and in 2011 and 2012 with the Certificate of Excellence from the International City/County Management Association (ICMA) for its dedication to improving governmental performance. In 2010, 2011 and 2012, the Sunshine Review awarded Albany an A+ perfect score for government transparency and online accessibility with its website along with other government agencies from around the country. Also in September 2010, the League of Oregon Cities awarded Albany the Good Governance Award for the "Where Does My Money Go? and Albany Dashboard" web applications and featured Albany for governmental transparency. In January 2011, Government Computer News cited Albany as one of ten "Top Public Sector Websites" in the nation for government transparency.
=== Generic names === Benorterone is the generic name of the drug and its INNTooltip International Nonproprietary Name and USANTooltip United States Adopted Name. It is also known by its developmental code names SKF-7690 and FC-612.
Sources: en.wikipedia.org
Head of Change and Labs, Information and Digital Directorate, Foreign, Commonwealth and Development Office. For services to British Foreign Policy. Dr. Rosemary Joy Trevelyan. Director, The Tropical Biology Association. For services to Environmental Science and International Conservation. Pamela Vipond. Deputy Director, Olympic Solidarity, the International Olympic Committee. For services to Sport. Paul Walker. Co-Founder and Co-Director, Wildtracks, Belize. For services to Conservation and Biodiversity in Belize. Zoe Elizabeth Walker. Co-Founder and Co-Director, Wildtracks, Belize. For services to Conservation and Biodiversity in Belize. David Justin Warmback. Honorary Consul, Durban, South Africa. For services to British Nationals in South Africa. Christopher Michael Wicker. President and Trustee, Hertford British Hospital Charity; Secretary General, Save the Valletta Skyline Appeal. For services to Charity and to British Nationals in France and Malta. Steven Leonard Williams. Kyaninga Child Development Centre and Kyaninga Forest Foundation, Uganda. For services to Disabled Children and Local Communities in Western Uganda.
== Methods == In laser microprobe mass analysis, a highly focused laser beam is pulsed on a micro sample usually with a volume of approximately 1 microliter. The resulting ions generated by this laser are then analyzed with time-of-flight mass spectrometry to give composition, concentration, and in the case of organic molecules structural information. Unlike other methods of microprobe analysis which involve ions or electrons, the LMMS microproble fires an ultraviolet pulse in order to create ions.
i.e. the baseline vaccination rate should be greater than the "mandatory vaccination" threshold, which, in case of exemption, cannot hold. Thus, "rational" exemption might be myopic since it is based only on the current low incidence due to high vaccine coverage, instead taking into account future resurgence of infection due to coverage decline.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.